Roberto Mina
Expert from University of Turin, Turin, IT
Best podcasts with Roberto Mina
Ranked by the Snipd community
Jul 25, 2022 • 28min
What are the pros and cons of bispecific antibodies for multiple myeloma?
Experts Roberto Mina and Andrzej J. Jakubowiak discuss the pros and cons of bispecific antibodies for multiple myeloma, highlighting MajesTEC-1 and MagnetisMM-1 trials, efficacy, response rates, challenges like infection risks, comparison to CAR T-cell therapies, and sequencing of therapies in myeloma treatment.
